Specifically, increased CD36 gene expression levels indicate an unfavorable prognostic value in 354 patients with stomach cancer (P<.001), and increased FABP7 gene expression levels indicate an unfavorable prognostic value in 877 patients with renal cancer (P<.001), yet indicate a favorable prognostic value in 1075 patients with breast cancer. Here, FABP7 is linked to gastric cancer.